7月30日 - ** 基因编辑公司Prime Medicine PRME.O寻求增资，股价在延时交易中下跌9.4%，至3.55美元
** 总部位于马萨诸塞州剑桥市的PRME开始发行股票 (link)；交易规模未披露
** 道明高文和墨尔本银行是联合账簿管理人
** 根据伦敦证券交易所的数据，该公司已发行约 1.345 亿股，市值约 5.27 亿美元
** PRME 股价周三上涨 2.3%，收于 3.92 美元。该股 7 月份上涨了约 59%，今年累计上涨了 34
** 12 位分析师中有 8 位将该股评为 "强力买入 "或 "买入"，其余评为 "持有"，中位 PT 为 8 美元 - LSEG
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.